Together, these results confirmed that mRNA- and protein- based antigen incorporating multiple epitopes were able to induce both MHC class I and II immune responses, although with different preference for MHC-restricted presentation, which may contribute to a broad mobilization of the MHC system to augment anti-tumor immunity. Here, HLA-C is linked to neoplasm.